États-Unis · Actualité générale · The Boston Globe

Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives

Publié par The Boston Globe · États-Unis il y a 9 h

The FDA officially warned patients not to use compounded GLP-1s this month unless an individual’s medical needs cannot be met by approved name-brand drugs.

Lire l'article complet sur The Boston Globe Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.bostonglobe.com)

Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives

À lire aussi

Cali judge blasts Meta’s ‘attorney-client privilege’ swag hats, rejects company’s request to use AI for document review

Pope Leo's tests show he needs no further treatment for lung cancer, his doctors say

Flanagan reverses course, says she was a Phi Beta Kappa member after all

Israeli military arrests U.S. Congressional nominee, dozens of rabbis

Pope Leo won't need more treatment after cancer surgery, doctors say

As midterms near, bipartisan furor grows over Trump targeting Ukraine

Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives

Partager

À lire aussi

Cali judge blasts Meta’s ‘attorney-client privilege’ swag hats, rejects company’s request to use AI for document review

Pope Leo's tests show he needs no further treatment for lung cancer, his doctors say

Flanagan reverses course, says she was a Phi Beta Kappa member after all

Israeli military arrests U.S. Congressional nominee, dozens of rabbis

Pope Leo won't need more treatment after cancer surgery, doctors say

As midterms near, bipartisan furor grows over Trump targeting Ukraine